Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.
Open Access
- 1 February 1977
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 40 (2), 162-167
- https://doi.org/10.1136/jnnp.40.2.162
Abstract
It has been suggested that the therapeutic response to levodopa in patients with Parkinson's disease may be related to changes in plasma growth hormone concentration. In order to examine this problem, we have determined plasma DOPA and growth hormone levels after a standard oral levodopa load in 32 patients with Parkinson's disease. Levodopa caused an increase in plasma growth hormone concentration in 30 subjects. The magnitude and timing of this growth hormone response was not related to the clinical response, the presence or absence of response swings, or the occurrence of dyskinesias. The growth hormone response to levodopa is normal in patients with Parkinson's disease and not altered by long-term levodopa treatment.This publication has 23 references indexed in Scilit:
- Modification of the Actions of Some Neuroactive Drugs by Growth HormoneArchives of Neurology, 1976
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976
- On‐off responseNeurology, 1975
- Patterns of clinical response and plasma dopa levels in Parkinson's diseaseNeurology, 1975
- Bromocriptine in ParkinsonismBMJ, 1974
- Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylaseJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Growth Hormone Responses to L-Dopa in Depressed PatientsScience, 1972
- A method for the determination of dopa and 3-O-methyldopa in the plasma of parkinsonian patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- POSTMENOPAUSAL BLEEDING: ANOTHER SIDE-EFFECT OF LEVODOPAThe Lancet, 1971
- A Sensitive Double Antibody Immunoassay for Human Growth Hormone in PlasmaNature, 1964